Advantage of liver stiffness measurement before and after direct-acting antiviral therapy to predict hepatocellular carcinoma and exacerbation of esophageal varices in chronic hepatitis C

scientific article published on 12 January 2020

Advantage of liver stiffness measurement before and after direct-acting antiviral therapy to predict hepatocellular carcinoma and exacerbation of esophageal varices in chronic hepatitis C is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/HEPR.13467
P698PubMed publication ID31785120

P50authorTetsuya HosakaQ56223851
Norio AkutaQ87747459
Shunichiro FujiyamaQ88224889
Nobuhiko OgasawaraQ88981825
Yusuke KawamuraQ90407021
Hitomi SezakiQ92198438
Kenji IkedaQ114433562
Hiromitsu KumadaQ114433568
Fumitaka SuzukiQ114923480
Masahiro KobayashiQ114923755
Yoshiyuki SuzukiQ114923935
Yasuji AraseQ114924322
Satoshi SaitoQ114924602
P433issue4
P921main subjectvaricose veinsQ201180
chronic hepatitis CQ55779873
P304page(s)426-438
P577publication date2020-01-12
P1433published inHepatology ResearchQ15752035
P1476titleAdvantage of liver stiffness measurement before and after direct-acting antiviral therapy to predict hepatocellular carcinoma and exacerbation of esophageal varices in chronic hepatitis C
P478volume50

Search more.